health.wusf.usf.edu2d
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
FierceBiotech4d
AbbVie's dopamine-focused Parkinson's treatment reduces disease burden in phase 3 trial
AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That ...
Scientists reexamine dopamine’s role in the placebo effect
This system relies on the neurotransmitter dopamine, and the experiment that Bingel and her team document in the paper tested ...
Neuroscience News6d
Dopamine Not Essential for Placebo Effect in Pain Relief
New research reveals that dopamine is not directly responsible for the formation of placebo analgesia, contrary to previous ...
ETX Daily Up on MSN14h
New drug for schizophrenics has experts excited
New drug for schizophrenics has experts excited Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. "This drug takes ...
FDA approves new schizophrenia drug
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
Neuroscience News3d
Unexpected Sounds Boost Dopamine, Leading to Riskier Decisions
A new study shows that unexpected sounds can cause dopamine bursts in the brain, which may lead to riskier decision-making.